Inhibition of Interleukin 2 (IL-2)-stimulated tyrosine kinase activity by leflunomide
- 1 August 1994
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 41 (2) , C279-C282
- https://doi.org/10.1007/bf01987669
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomideFEBS Letters, 1993
- LEFLUNOMIDE, A NOVEL IMMUNOSUPPRESSIVE AGENTTransplantation, 1993
- T cell antigen receptor signal transduction: A tale of tails and cytoplasmic protein-tyrosine kinasesCell, 1993
- Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinasesCell, 1992
- c-fos gene induction by interleukin 2: identification of the critical cytoplasmic regions within the interleukin 2 receptor beta chain.Proceedings of the National Academy of Sciences, 1992
- T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck.Proceedings of the National Academy of Sciences, 1991
- A single amino acid mutation in a protein antigen abrogates presentation of certain T cell determinants.The Journal of Experimental Medicine, 1989